Current NDC auxiliary source row compounder:549

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 72627-2101
Product Ndc: 72627-2101
Product Ndc Digits: 726272101
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Testosterone Cypionate
Proprietary Name Suffix: [empty]
Nonproprietary Name: Testosterone Cypionate
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR; SUBCUTANEOUS
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Empower Pharma
Establishment Name: Empower Pharma
Establishment Fei: [empty]
Substance Name: TESTOSTERONE CYPIONATE
Active Ingredients Info: 50 mg/1 mL
History Active Ingredients Raw: TESTOSTERONE CYPIONATE
History Active Ingredients Info Raw: 50 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: CIII
Package Ndc Raw: 72627-2101-3
Package Ndc: 72627-2101-3
Package Ndc Digits: 7262721013
Package Ndc11: 72627210103
Package Description: 5 mL in 1 VIAL, MULTI-DOSE (72627-2101-3)
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:549
Source Row Number: 549
Source Row Hash: 89110dbcab6ed1ad55aa2757dea0a279f5d2a853b39241f73257c3c57c5e796a
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; SUBCUTANEOUS",
    "PRODUCTNDC": "72627-2101",
    "DEASCHEDULE": "CIII",
    "LABELERNAME": "Empower Pharma",
    "SUBSTANCENAME": "TESTOSTERONE CYPIONATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "72627-2101-3",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Testosterone Cypionate",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Testosterone Cypionate",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL, MULTI-DOSE (72627-2101-3) ",
    "ACTIVEINGREDIENTSINFO": "50 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:549
Source Row Number: 549
Status Scope: package
Lookup Ndc: 72627-2101-3
Lookup Ndc Digits: 7262721013
Product Ndc: 72627-2101
Product Ndc Digits: 726272101
Package Ndc: 72627-2101-3
Package Ndc Digits: 7262721013
Package Ndc11: 72627210103
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-2
Reporting Period: 2025-2
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 89110dbcab6ed1ad55aa2757dea0a279f5d2a853b39241f73257c3c57c5e796a
Import Run Id: 20261015T162751Z
Loaded At: 2026-10-15 16:32:20